BiotechTube
Home/Lutris Pharma/Laura Millichamp, Ph.D.
LM

Laura Millichamp, Ph.D.

Director, Chemistry Manufacturing Control

Lutris Pharma

Therapeutic Areas

Oncology

Lutris Pharma Pipeline

DrugIndicationPhase
LUT014EGFR inhibitor‑induced acneiform lesions in metastatic colorectal cancerPhase 2

Leadership Team at Lutris Pharma

SR
Sumant Ramachandra, M.D., Ph.D., MBA
Chief Executive Officer and Board Director
JP
John Paul Waymack, M.D., Sc.D.
Director, Regulatory Affairs
CJ
Colleen Johnson, M.S, DABT
Director, Pre‑Clinical Development
View full Lutris Pharma profile